Navigation Links
Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
Date:10/22/2013

SEOUL, South Korea, Oct. 22, 2013 /PRNewswire/ -- Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction. Terms of the agreement will not be disclosed, including financial terms and products to be manufactured.

(Photo: http://photos.prnewswire.com/prnh/20131022/HK01710 )
(Photo: http://www.prnasia.com/sa/2013/10/22/2013102214483444486.html )

"We are pleased to announce this strategic manufacturing relationship with Roche and look forward to delivering best-in-class manufacturing services with the highest global quality standards," said Tae-Han Kim, president and CEO of Samsung BioLogics. "This collaboration with the world's largest biotech company is an important milestone for Samsung as it validates our long term strategy of becoming a leader in biopharmaceutical manufacturing."

About Samsung BioLogics

Samsung BioLogics is a full-service provider of quality-driven contract process development and cGMP manufacturing to the global biopharmaceutical industry. Our facilities are custom designed for monoclonal antibody & recombinant protein production with maximum flexibility. Our one-stop services include cell line generation, process and analytical method development, analytical services, clinical and commercial bulk cGMP manufacturing of drug substance and drug product meeting the highest standards of quality and global regulatory compliance. For additional information about the company, please visit '/>"/>

SOURCE Samsung BioLogics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Samsung Thales signs Development Agreement with Novelda
2. iLuv Now Shipping Protective and Stylish Accessories for the Just-Announced Samsung GALAXY Note 8.0
3. iLuv Announces a New Lineup of Cases and Accessories for the New Samsung GALAXY Tab 3
4. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
5. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
6. Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round
7. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
8. Adeona Becomes Synthetic Biologics, Inc.
9. Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
10. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimestaâ„¢ for Multiple Sclerosis
11. CMC Biologics Highlights Technical Acumen at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory, Molecular ... Forecast 2015 to 2019 - Global Version" ... developments especially in the area of molecular diagnostics ... growing and evolving world market that is moving ...
(Date:5/5/2015)...   Tocagen Inc. , a clinical-stage immuno-oncology ... , M.D., a venture partner at New Enterprise ... of directors of Tocagen. Dr. Parkinson has more ... development, including leading clinical activities at Amgen and ... cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and Vectibix®, ...
(Date:5/5/2015)... May 05, 2015 Synedgen Inc. is ... as Regulatory Affairs Manager. , Dr. Nguyen brings to ... juncture for the company as it moves forward in ... over the next two years. Dr. Nguyen will lead ... the regulatory key documents that must be completed in ...
(Date:5/4/2015)... , May 4, 2015 /PRNewswire/ - JSS Medical Research Inc., a ... today that it concluded the acquisition of Max Neeman International (MNI), ... Additional regional offices are located in Ahmedabad, Bangalore ... . Through a US subsidiary, a regional office is located ... expansion is supported by the recent equity investment transaction into JSS ...
Breaking Biology Technology:Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4Synedgen Announces the Appointment of Regulatory Affairs Manager 2JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4
... Volker Wippersteg, Katja Kapp, Werner Kunz, ... D-40225 Dsseldorf, Germany, , , ... Schistosomes are parasitic helminths that cause ... a tropical disease of worldwide significance (Savioli et al.1997). , ...
... Peter M Kilby, Roche Discovery Welwyn, 40 Broadwater Road, Welwyn , ... Syngenta, Jealotts Hill International Research Centre, Bracknell, Berkshire, , ... , Abstract , ... (Figure 1) for , running 2-D SDS-PAGE slab gels ...
... Jacqueline Boultwood, Gail M. Abrahamson, and J.,S. Wainscoat, Leukemia Research Fund, ... Kingdom , , ... Tumor diagnoses, DNA fingerprinting, ... For,example, peripheral blood may be used as a source from solid,tumors, ...
Cached Biology Technology:Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 2Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 3Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 4Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 5Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 7Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 8Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 9Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 2Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 3Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 4Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 5PFGE Analysis of Chromosomal DNA From a Single Hair Root 2
(Date:4/1/2015)... Medisafe ™, the leading global medication management platform with ... Android smartphones and tablets, announces today that ... allow patients to track and correlate their adherence directly ... be able to visualize in real-time how taking medication ... glucose levels and blood pressure. "Patients need ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/26/2015)... March 26, 2015 The Granite ... recreation and athletic club, today announced it has implemented ... freedom of movement for members and staff, while restricting ... comprehensive process, we selected FST,s IMID Access system because ... for our members and staff, in addition to unparalleled ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... Scientists at The Scripps Research Institute have discovered that ... schizophrenic subjects. The findings suggest that drugs already ... a treatment for schizophrenia and related conditions in the elderly. ... Nature journal, Translational Psychiatry , shows the ...
... of many serious diseases such as cancer, Alzheimer,s, arteriosclerosis ... to excessive amounts of electrically charged, aggressive oxygen compounds. ... processes, but also in the case of ongoing stress, ... stress is too high, it overwhelms the body,s natural ...
... fish crawling on stumpy limbs from a shrinking desert ... a leading theory for the evolutionary transition between fish ... adaptation to changing environmental conditions, however, may, itself, be ... Oregon scientist Gregory J. Retallack, professor of geological sciences, ...
Cached Biology News:Scripps Research scientists discover a brain cell malfunction in schizophrenia 2Scripps Research scientists discover a brain cell malfunction in schizophrenia 3Scripps Research scientists discover a brain cell malfunction in schizophrenia 4A new theory emerges for where some fish became 4-limbed creatures 2
... In an effort to help promote genomics-based research ... aureus ORFmer set that contains PCR primers to ... COL strain1. In addition, primer pairs are included ... the Mu50 and N315 strains of S. aureus. ...
... increases your lab productivity and allows you to ... compliance. Move ahead beyond traditional paper-based weighing processes ... *Instruments supported: ... AG, XS, XP, PR, SR, PG-S, PG, SG, ...
... rapid analytical to medium scale affinity purification ... vectors. Sufficient reagents are provided for purification ... under native or denaturing conditions. Crude samples ... retains STag fusion proteins. After unbound proteins ...
Useful for determination of glucose and ATP. Packaging: Package sizes are based on hexokinase units. Preparation Unit Definition: One unit will phosphorylate 1.0 mol of D -glucose per min at pH ...
Biology Products: